Patent intelligence · US
US 8986653
Labeled iodinated tropane formulation
Labeled iodinated tropane formulation
Patent details — US 8986653
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 24, 2015
- Expiration
- Mar 19, 2035
- Applicant
- Alseres Pharmaceuticals, Inc.
- Claims
- 3
- CPC classes
- A61K, A61K51/0448, A61K51/0455
Quick answer
US 8986653 (Labeled iodinated tropane formulation) is held by Alseres Pharmaceuticals, Inc.. Status: granted. Granted Mar 24, 2015. Expires Mar 19, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Alseres Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K51/0448, A61K51/0455
More from Alseres Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12409197
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 12214002
Compositions and methods for treating antibiotic resistance
granted -
US 12083151
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11918612
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11730775
Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof
granted -
US 11701394
Compositions and methods for treating cholestatic disease
granted -
US 11666612
Network-based microbial compositions and methods
granted -
US 11464812
Synergistic bacterial compositions and methods of production and use thereof
granted
Frequently asked questions
What is US patent 8986653?
US 8986653 (Labeled iodinated tropane formulation) is held by Alseres Pharmaceuticals, Inc.. Status: granted. Granted Mar 24, 2015. Expires Mar 19, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8986653?
Alseres Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 36 pharmaceutical patents for this assignee.
When does US 8986653 expire?
Our index shows an expiration date of Mar 19, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.